Castle Biosciences
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell CSTL and other ETFs, options, and stocks.About CSTL
Castle Biosciences, Inc.is a molecular diagnostics company offering innovative test solutions to aid clinicians in the diagnosis and treatment of dermatologic cancers, barrett’s esophagus, uveal melanoma, and in the treatment of mental health conditions. The firm offers DecisionDx-Melanoma, a proprietary multi-gene expression profile (GEP) test that predicts the risk of metastasis and recurrence for patients diagnosed with invasive cutaneous melanoma.
CSTL Key Statistics
Stock Snapshot
As of today, Castle Biosciences(CSTL) shares are valued at $39.18. The company's market cap stands at 1.14B, with a P/E ratio of -84.36.
On 2025-12-12, Castle Biosciences(CSTL) stock traded between a low of $38.06 and a high of $39.18. Shares are currently priced at $39.18, which is +2.9% above the low and 0.0% below the high.
The Castle Biosciences(CSTL)'s current trading volume is 117.57K, compared to an average daily volume of 414.06K.
In the last year, Castle Biosciences(CSTL) shares hit a 52-week high of $40.61 and a 52-week low of $14.59.
In the last year, Castle Biosciences(CSTL) shares hit a 52-week high of $40.61 and a 52-week low of $14.59.
CSTL News
Castle Biosciences (CSTL) announced the publication of a new systematic review and meta-analysis, SRMA, demonstrating that the TissueCypher Barrett’s Esophagus...
Castle Biosciences (CSTL) has quietly turned into one of this year’s surprising healthcare winners, with the stock up about 68% over the past 3 months and rough...
Castle Biosciences (CSTL) announced the publication of an independent expert consensus paper titled “31-Gene Expression Profiling for Cutaneous Melanoma: An Exp...